ABSTRACT
The first synthesis of the natural product (+)-mutisianthol was accomplished in 11 steps and in 21% overall yield from 2-methylanisole. The synthesis of its enantiomer was also performed in a similar overall yield. The absolute configuration of the sesquiterpene (+)-mutisianthol was assigned as (1S,3R). Key steps in the route are the asymmetric hydrogenation of a nonfunctionalized olefin using chiral iridium catalysts and the ring contraction of 1,2-dihydronaphthalenes using thallium(III) or iodine(III). The target molecules show moderate activity against the human tumor cell lines SF-295, HCT-8, and MDA-MB-435.
Subject(s)
Anisoles/chemistry , Antineoplastic Agents/chemical synthesis , Biological Products/chemical synthesis , Sesquiterpenes/chemical synthesis , Alkenes/chemistry , Antineoplastic Agents/pharmacology , Biological Products/pharmacology , Cell Line, Tumor , Drug Screening Assays, Antitumor , Humans , Hydrogenation , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , StereoisomerismABSTRACT
In this work we describe the cyclofunctionalization of eleven differently substituted alkenyl-beta-dicarbonyl compounds, employing three electrophilic reagents, namely, iodine, p-methoxyphenyltellurium trichloride, and phenylselenenyl bromide. The reactions occur through the enolic form of the substrates, to afford the corresponding iodo-, telluro-, or selenocyclic enol ethers. Substrates bearing trisubstituted double bonds failed in reacting with the selenium and tellurium reagents. In general, beta-diketones reacted faster than beta-keto esters with the three studied electrophiles.
